For the Inventor, By the Inventor

Enter assignee name

Exton, PA, United States of America

3-dimensional Pharmaceuticals, Inc.

USPTO Granted Patents = 76

Forward Citations = 1,534

Loading Chart...

Loading Chart...

89 inventors (with patents filed for the assignee):

Bruce Edward Tomczuk (32 out of 44 patents)

Richard M Soll (32 out of 46 patents)

Tianbao Lu (30 out of 64 patents)

4. Thomas P Markotan (19 out of 30 patents)

5. Francis Raymond Salemme (18 out of 30 patents)

6. Carl R Illig (17 out of 90 patents)

7. Roger Francis Bone (16 out of 24 patents)

8. Michael W Pantoliano (14 out of 24 patents)

9. Nalin L Subasinghe (12 out of 12 patents)

10. Barry A Springer (9 out of 13 patents)

11. Dimitris K Agrafiotis (9 out of 20 patents)

12. Colleen Siedem (8 out of 10 patents)

13. Cynthia L Fedde (7 out of 8 patents)

14. M Jonathan Rudolph (6 out of 12 patents)

15. Alexander W Rhind (6 out of 7 patents)

Core Competencies:

Complement Cascade Inhibitors

C-fms Kinase Inhibitors

Protease Inhibitors

Integrin Antagonists

Aminoguanidines

Thiophene Amidines

Quinazolinones

Heteroaryl Compounds

Chemical Compound Identification

Multi-Dimensional Data Mapping

Ligand Development

Pest GABA Receptor Ligands

76 patents: Sort by Forward Citations

1. 7482376 - Conjugated complement cascade inhibitors (2009-01-27),

2. 7429603 - C-fms kinase inhibitors (2008-09-30),

3. 7241789 - Substituted indoles and their use as integrin antagonists (2007-07-10),

4. 7138530 - Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions (2006-11-21),

5. 7138374 - Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137 (2006-11-21),

6. 7109354 - Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions (2006-09-19),

7. 7060706 - Quinazolinones (2006-06-13),

8. 6962942 - Azacycloalkanone serine protease inhibitors (2005-11-08),

9. 6900231 - Aminopyridyl-substituted phenyl acetamides as protease inhibitors (2005-05-31),

10. 6890930 - Quinazolinones (2005-05-10),

11. 6872730 - Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists (2005-03-29),

12. 6767722 - Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, Aspartate 101 or Leucine 137 (2004-07-27),

13. 6737404 - Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, aspartate 101 or leucine 137 (2004-05-18),

14. 6730783 - Process for preparing aminoguanidines and alkoxyguanidines as protease inhibitors (2004-05-04),

15. 6706765 - Aminoguanidines and alkoxyguanidines as protease inhibitors (2004-03-16),

3-Dimensional Pharmaceuticals, Inc. is a leading biopharmaceutical company specializing in the discovery and development of innovative therapeutics. With a focus on 3-dimensional drug design and precision medicine, we strive to create breakthrough treatments for a range of diseases. Our research and development efforts are driven by a dedicated team of scientists and experts in computational chemistry, molecular biology, and drug discovery. Through strategic collaborations and internal capabilities, we aim to bring transformative medicines to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

76 Patents

#5 in Exton, PA

#177 in Pennsylvania

#4,652 in US

#9,510 in the World

Exton, PA, United States of America

3-dimensional Pharmaceuticals, Inc.

Forward Citations = 1,534

89 inventors:

Bruce Edward Tomczuk (32 out of 44 patents)

Richard M Soll (32 out of 46 patents)

Tianbao Lu (30 out of 64 patents)

4. Thomas P Markotan (19 out of 30 patents)

5. Francis Raymond Salemme (18 out of 30 patents)

Please report any incorrect information to support@idiyas.com

Loading…